I was recently asked “What distinguishes SBIR/STTR companies that successfully transition into investor-ready ventures? Are there certain characteristics?” Here are a couple of points that struck me right away.
January 2, 2026
Commercialization Support
January 2, 2026
Foreign Risk vs. SBA Red Tape Hotline
This summer we posted about the unfortunate circumstances some of our NIH applicants have had with failing to pass the foreign risk assessment.
January 2, 2026
Is your innovation right for Army FUZE?
The Defense TechConnect Innovation Summit, in conjunction with the SBIR/STTR Fall Innovation Conference was recently held in National Harbor.
September 17, 2025
Celebrating Innovation: Highlights from the SBIR Advance 10th Anniversary Showcase
On Thursday, September 11th, we gathered to celebrate the achievements of Wisconsin’s top tech entrepreneurs at the SBIR Advance 10th Anniversary Showcase.
August 29, 2025
NIH Applications rejected for failing Foreign Risk Assessment
Recently we have had numerous NIH SBIR/STTR proposals rejected because they have failed the foreign risk assessment.
August 25, 2025
Safeguarding Originality: NIH’s New Limits on AI Use and Application Volume
Note: Ironically written by ChatGPT and edited by real humans.
August 19, 2025
NIST funds diverse innovations with $1.8M in SBIR grants
The National Institute of Standards and Technology (NIST) has awarded over $1.
August 11, 2025
Prompting TurboInnovate with CTC
You may recall that the CTC has a license to the Omnisync TurboInnovate platform.
July 25, 2025
Non-SBIR DoD funding for your innovation
The Department of Defense has funding for your innovation outside of SBIR, and we want to help you tap into it! The following units provide support for most Technology Readiness Levels (TRLs) through various solicitations, partnerships, and pitches.
July 9, 2025
How the OBBBA Repeal of Section 174 Could Supercharge Your Startup
Big news for startups and innovators: The One Big Beautiful Bill Act (OBBBA) has reversed the “Innovation Tax” under Section 174.